Physician profile
Ndey Diallo
NPI 1538435987
$2,607.33
in general payments reported to CMS, 2019-2025
37 companies · $43.92 in 2025
The $43.92 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $405 · 2021: $520 · 2022: $432 · 2023: $340 · 2024: $363 · 2025: $43.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.93 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $341.55 | 2019-2022 | |
| Astellas Pharma US INC | $334.87 | 2019-2025 | Veozah |
| Abbvie INC. | $291.35 | 2019-2023 | Lo Loestrin Fe |
| Amgen INC. | $231.65 | 2019-2024 | Evenity, Prolia |
| Exeltis, USA INC. | $109.75 | 2019-2024 | Slynd |
| Daiichi Sankyo INC. | $109.41 | 2019-2023 | Injectafer |
| Pfizer INC. | $103.03 | 2019-2025 | |
| Agile Therapeutics, INC. | $76.13 | 2021-2023 | Twirla |
| Vanda Pharmaceuticals INC. | $74.05 | 2019 | |
| Mylan Pharmaceuticals INC. | $71.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $67.18 | 2019-2023 | Gardasil 9 |
| Mayne Pharma Commercial LLC | $63.81 | 2021-2024 | |
| Coopersurgical, INC. | $61.55 | 2019-2021 | |
| Avion Pharmaceuticals | $57.81 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.82 | 2020-2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $44.55 | 2021-2022 | |
| Biogen, INC. | $43.35 | 2022 | |
| Evofem Biosciences, INC. | $42.84 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $42.52 | 2023 | Myfembree |
| Shield Therapeutics INC | $38.12 | 2023 | Accrufer |
| Medtronic, INC. | $37.36 | 2023 | Ligasure |
| Hologic Sales and Service, LLC | $35.03 | 2019-2021 | |
| Ge Healthcare | $30.88 | 2020 | |
| Amarin Pharma, INC. | $29.91 | 2019-2020 | |
| Organon LLC | $28.21 | 2023-2024 | Nexplanon |
| Scynexis, INC. | $27.56 | 2022 | |
| Exact Sciences Corporation | $20.33 | 2024 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $20.28 | 2022 | |
| Lilly USA, LLC | $18.39 | 2021 | |
| Roche Diagnostics Corporation | $15.06 | 2021 | |
| Kci USA, INC. | $14.61 | 2019 | |
| Zyla Life Sciences, INC. | $14.50 | 2020 | |
| Cepheid | $14.34 | 2023 | |
| Duchesnay USA Incorporated | $13.68 | 2019 | |
| Novo Nordisk INC | $13.21 | 2023 | Wegovy |
| Vertical Pharmaceuticals, LLC | $12.20 | 2019 | |
| Millicent US INC | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ndey Diallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.